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Abstract: Chronic diseases and decreased physiological function in geriatric patients play a role in the increased 
Potentially Inappropriate Prescribing (PIP) and Adverse Drug Reactions (ADR). STOPP/START Criteria 
(Screening Tool of Older Person's Prescriptions/Screening Tool to Alert to Right Treatment) is one of the 
screening tools to identify Potentially Inappropriate Prescribing. The purpose of this study was to find out 
how much Potentially Inappropriate Medicines (PIM) potential and Potency Prescribing Omissions (PPO) at 
X hospital using STOPP START toolkit. This was a non-experimental descriptive study. Samples were 
collected retrospective in January-March 2017. STOPP/START criteria were used as a screening tool to 
identify Potentially Inappropriate Medication (PIM) and Potential Prescribing Omissions (PPO). In 91 
samples of outpatient geriatric at X hospital, the potential for PIM according to the STOPP Criteria was 
1.9% of a total of 560 drugs with criteria were for the administration of benzodiazepines in patients with a 
history of falls, anticholinergics and antipsychotics in dementia patients, glimepiride administration in 
geriatric patients with DM type 2. For the potential of negligence in drug administration according to the 
START Criteria, there was 3.8% with the most occurrence being the administration of acetylcholinesterase 
inhibitors in dementia patients. Of the 560 medications administered to outpatient geriatric patients, 1.9% 
were included in the STOPP criteria and 3.8% included in the START criteria. 
1 INTRODUCTION 
The phenomenon of population ageing is a 
phenomenon that has occurred worldwide. Between 
2015 and 2050, the population of 60 years or older is 
expected to increase from 12% to 22%. By 2050 it is 
estimated that the number of elderly people in the 
world reaches 2 billion inhabitants (Iona et al. 
2015). In Indonesia, the elderly population in 2017 
numbered approximately 23.66 million people 
(9.03%) and is estimated to increase to 48.19 million 
in 2035 (Kementrian Kesehatan RI 2017). 
A large number of elderly population in 
Indonesia will have an impact on the health sector in 
the form of health decline which resulting in 
increased service costs (Kementrian Kesehatan RI 
2017). Increasing age in the elderly can alter the 
body's physiological system, but it may also alter the 
pharmacokinetic and pharmacodynamic profile of 
the drug. The elderly group has multiple 
comorbidities and is more often hospitalized, which 
increases the risk of polypharmacy and the potential 
for inappropriate prescribing (Corsonello et al. 
2009). 
Some lists of drugs have been made by experts 
for use by medical circles in the treatment of 
geriatric patients i.e. Beers Criteria (The American 
Geriatrics Society  2012) or Canadian Criteria 
(McLeod et al. 1997). The STOPP/START Criteria 
(Screening Tool for Older Person's Prescriptions / 
Screening Tool to Alert to Right Treatment) were 
made to identify potentially inappropriate 
medication (PIM) (Gallagher et al. 2011). 
STOPP/START criteria were made according to the 
body's physiological system consisting of 80 STOPP 
Criteria and 34 START Criteria (O’Mahony et al. 
2014). The STOPP/START criteria were created in 
2003 with the aim of addressing the possible 
shortcomings of the Beers criteria. The criteria 
consist of Potentially Inappropriate Medication 
(PIM) described by STOPP, and Potential 
Prescribing Omissions (PPO) prescriptions, 
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 described by the START. This START method is 
intended to improve treatment success in geriatric 
patients (O'Mahony et al. 2014).  
The result of PIM identification with STOPP and 
START screening tool has not been well 
documented in Indonesia especially in DKI Jakarta 
hospital. X Hospital (RSUPN DR. Cipto 
Mangunkusumo) is a government hospital located in 
Central Jakarta and is a referral of the National 
Geriatric Center. From the results of the survey to 
the hospital, the outpatient geriatric patients from 
January to March 2017 at X hospital were numbered 
1047 patients. 
2 METHOD 
This experiment was a cross sectional study. 
Samples were collected retrospectively in January - 
March 2017. STOPP/START criteria were used as a 
screening tool to identify Potentially Inappropriate 
Medication (PIM) and Potential Prescribing 
Omissions (PPO). The total population of 1047 
patients and samples taken according to Taro 
Yamane formula amounted to 91 using systematic 
sampling (Moch Imron 2011). Inclusion criteria 
were geriatrics aged 60 years or older, received the 
medicine, diagnosis data, physical examination data 
and laboratory data required. The exclusion criteria 
were patients with forced home, and the patient died. 
The data collected were secondary data in the 
form of medical record number, patient initials, age, 
sex, diagnosis, comorbidities, physical examination, 
drugs used and laboratory information. Data 
analyzed using STOPP/START Criteria to determine 
the precision of prescribing that adjusted to the 
medical record of the patients. 
3 RESULTS 
The results of the study showed that improper use of 
medicines according to STOPP criteria included 
giving benzodiazepines which could potentially 
cause a risk of falls in the elderly. Besides that, there 
were also the used of drug duplication, 
anticholinergics, antipsychotics and Glimepiride 
(Table 1). 
The results study, the PPO according to the 
START Criteria numbered to 3.8% or 21 incidents. 
The highest incidence in this study was an omission 
of acetylcholinesterase inhibitor therapy in 5 
dementia patients, alpha-1 blocker therapy and 5a 
reductase inhibitor in patients with BPH of 5 cases, 
Table 2. The Frequency of PPO According to Criteria START 
Criteria 
Code Descriptions N 
C3 Acetylcholinesterase inhibitors in dementia patients 5
G1 Alpha 1 blocker in patients with BPH 5
G2 5a reductase inhibitor in BPH patients 5
E3 Vitamin D and calcium in patients with osteoporosis 3
A4 Antihypertensive in patients with blood pressure> 140 / 90mmHg 1
E6 Xanthine oxidase inhibitors in gout arthritis patients 1
C4 Topical prostaglandin or prostamide or topical beta blockers in glaucoma patients 1
 Total 21
 
Table 1. PIM Frequency According to STOPP Criteria 
Criteria 
Code Descriptions N 
K1 Benzodiazepin that increase the risk of falling in geriatric 4
A3 Concurrent use of one class drug or its derivatives 2
D8 Anticholinergics in geriatric patients with delirium or dementia 1
D9 Antipsychotics in the elderly with BPSD (dementia) 1
C3 Aspirin in the elderly with uncontrolled hypertension 1
J1 Glimepiride in the elderly with type 2 diabetes mellitus 1
 Total 10
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 respectively. Furthermore, vitamin D and calcium 
therapy were given in 3 patients with osteoporosis, 
antihypertensive in 1 geriatric patient with blood 
pressure> 140 / 90mmHg, xanthine oxidase inhibitor 
therapy in 1 patient with gout arthritis and topical 
prostaglandin or prostamide or beta-blocker therapy 
in 1 patient with glaucoma (Table 2). 
4 DISCUSSION 
The most prevalent PIM criteria were the use of 
benzodiazepine-class drugs in 4 geriatric patients 
(40%). The use of benzodiazepines class of drugs 
may lead to reduced sensory and impaired balance 
(O’Mahony et al. 2014). In the elderly the 
benzodiazepine profile may undergo changes related 
to altered cytochrome P450 enzyme activity 
(Sotaniemi et al. 1997) otherwise it may be caused 
by other things such as diminished albumin which 
leads to increased concentrations of benzodiazepines 
in a free form (Hammerlein et al. 1998). In the 
elderly there is also an increase in the sensitivity of 
benzodiazepines to the central nervous system 
(Hillmer et al. 2007; Sera et al. 2012; Naranjo et al. 
1995). In a previous study, more than 40% of elderly 
who received benzodiazepine-class drugs entered 
emergency care after falling out (Cengotitabengoa et 
al. 2018). 
Concurrent use of one class of drugs or the 
derivatives occurred to 2 patients (20%), i.e, the use 
of dopamine agonist (pramipexole and levodova) 
drugs. Drug duplication will increase as patients 
develop chronic illness and the range can reach 
40.38% to 43.50% with 1.45-1.62 duplications 
(Cheng et al. 2014). Drug duplication were 
associated with polypharmacy which may increase 
the risk of adverse drug reactions (Bushardt et al. 
2008). Constipation, nausea, headache and excessive 
daytime sleepiness are among adverse drug reactions 
of dopamine (Pagano et al. 2014; Tholfsen et al. 
2015). Other adverse drug reactions such as 
hallucinations (both visual and audio), peripheral 
edema, heart valve disorders to heart failure have 
been reported as an adverse drug reaction of 
dopamine agonist therapy (Lockett et al. 2015; 
Wood 2010). 
There is one incident (10%) of anticholinergics 
administered to dementia patients. The provision of 
anticholinergic prescriptions should be done 
cautiously given the side effects to the elderly. 
Adverse drug reactions of anticholinergic will 
worsen the state of dementia (O’Mahony et al. 2014; 
Gerretsen et al. 2011) . There is one incident (10%) 
of antipsychotics given in elderly patients. The 
antipsychotic administration was included in the 
STOPP Criteria as it may increase the risk of stroke 
in the elderly (O’Mahony et al. 2014). In previous 
studies, the use of antipsychotics in older adults may 
increase the cardiovascular risk to death. The risk 
will increase if the elderly develop dementia (Mittal 
et al. 2011). 
The use of aspirin in the elderly was one incident 
(10%). When aspirin was given to uncontrolled 
hypertension (> 140 mmHg and > 90 mmHg) 
patients, it will increase the risk of bleeding 
(O’Mahony et al. 2014; Lip 2011; Pisters et al. 
2010). 
Glimepiride used with caution in elderly patients 
as it may lead to hypoglycemia (Katzung et al. 
2012). In this study, there was one incident (10%), 
and in previous studies, there was an incidence of 
hypoglycemia in 23 patients out of a total of 143 
patients (Shihara et al. 2017). 
According to the START Criteria, there were 
three most potential Omissions in drug 
administration: acetylcholinesterase inhibitor 
therapy in dementia patients (23.8%),  alpha 1 
blocker therapy and 5a reductase inhibitor in patients 
with BPH (23.8%), vitamin D and calcium therapy 
in geriatric patients with osteoporosis. Study on the 
comparison of the use of acetylcholinesterase 
inhibitors with placebo found a significant 
difference seen from the value of ADAS-Cog (The 
Alzheimer’s Disease Assessment Scale–Cognitive 
subscale) and MMSE (Mini Mental State Exam) 
after patients were given therapy for six months 
(Mochammad et al. 2017). Acetylcholinesterase 
inhibitors not only improve cognitive function but 
can also increase psychological function and habits 
(DiSanto et al. 2013). 
Alpha 1 blockers administered together with a 5a 
reductase inhibitor are the START Criteria in BPH 
patients. In elderly who had moderate to severe 
prostate disturbance when given a combination of 
both drugs resulted in much better improvement 
compared with tamsulosin or dutasteride 
monotherapy (Roehrborn et al. 2008). Vitamin D 
and calcium therapy were PPO in 5 geriatric patients 
with osteoporosis. Vitamin D and calcium therapy 
are strongly recommended to improve the state of 
osteoporosis and prevent fractures (Weaver et al. 
2016). In the study had found that the used of 
Vitamin D and calcium in osteoporosis patients can 
reduce the risk of fracture in the elderly group 
(Weaver et al. 2016). 
Geriatric patients with blood pressure > 140 / 
90mmhg included to the START Criteria for not 
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 getting antihypertensive (O’Mahony et al. 2014). 
Blood pressure target for elderly (< 140/90mmHg), 
the treatment may be based on JNC8 guidelines and 
may be combined with expert consensus guidelines 
ACCF/AHA 2011 (Arthur et al. 2015). 
In this study, xanthine oxidase inhibitor therapy 
in gout patients include to the START Criteria. 
Febuxostat was recommended if elderly patients 
have moderate to severe renal impairment (Fravel et 
al. 2011). 
Geriatric patients with glaucoma who are not 
receiving antiglaucoma therapy (topical 
prostaglandin, prostamide or beta-blockers) included 
to the STOPP Criteria. Comparison of the 
effectiveness of topical prostaglandin (latanoprost 
bunod 0.024%) once daily in the afternoon showed 
better results than the topical beta blocker (timolol 
0.5%) twice daily given to glaucoma patients for 
three months (Medeiros et al. 2016). 
5 CONCLUSIONS 
From the results of this study, it could be concluded 
from 560 drugs given to outpatient geriatric patients 
at X hospital, there is 1.9% of PIM incidence for 
STOPP criteria and 3.8% incidence of PPO for 
START criteria. 
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